Johnson & Johnson launches multi-pronged response to coronavirus global public health threat

This article was originally published here

As part of this work, the Company has initiated efforts to develop a vaccine candidate against 2019-nCoV and broadly collaborate with others to screen a library of antiviral

The post Johnson & Johnson launches multi-pronged response to coronavirus global public health threat appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply